The Latest Trading Price of Pfizer Ltd is ₹ 4781 as of 06 May 15:30
. The P/E Ratio of Pfizer Ltd changed from 41.6 on March 2021 to 23.9 on March 2025 . This represents a CAGR of -10.49% over 5 yearsThe P/E Ratio of Source Natural Foods & Herbal Supplements Ltd changed from 28.2 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 10.38% over 5 years The Market Cap of Pfizer Ltd changed from ₹ 20684 crore on March 2021 to ₹ 18317 crore on March 2025 . This represents a CAGR of -2.40% over 5 yearsThe Market Cap of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 95.27 crore on March 2021 to ₹ 133.98 crore on March 2025 . This represents a CAGR of 7.06% over 5 years The revenue of Pfizer Ltd for the Dec '25 is ₹ 683.24 crore as compare to the Sep '25 revenue of ₹ 684.19 crore. This represent the decline of -0.14% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 20.3 crore as compare to the Sep '25 revenue of ₹ 16.95 crore. This represent the growth of 19.76% The ebitda of Pfizer Ltd for the Dec '25 is ₹ 208.2 crore as compare to the Sep '25 ebitda of ₹ 271.78 crore. This represent the decline of -23.39% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 1.53 crore as compare to the Sep '25 ebitda of ₹ 1.36 crore. This represent the growth of 12.5% The net profit of Pfizer Ltd changed from ₹ 150.71 crore to ₹ 141.84 crore over 7 quarters. This represents a CAGR of -3.41%
The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0.42 crore to ₹ 0.82 crore over 7 quarters. This represents a CAGR of 46.57%
The Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Pfizer Ltd
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.
About Source Natural Foods & Herbal Supplements Ltd
Source Natural Foods &Herbal Supplements Limited was initially incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India and provide allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.
Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.
Company focuses on such products which will bring Ayurveda in to individual's daily diet.
FAQs for the comparison of Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd
Which company has a larger market capitalization, Pfizer Ltd or Source Natural Foods & Herbal Supplements Ltd?
Market cap of Pfizer Ltd is 21,875 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 82 Cr
What are the key factors driving the stock performance of Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd?
The stock performance of Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd?
As of May 6, 2026, the Pfizer Ltd stock price is INR ₹4781.85. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹128.05.
How do dividend payouts of Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd compare?
To compare the dividend payouts of Pfizer Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.